Polwax Valuation
Is 1LW undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 1LW when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 1LW (€0.31) is trading below our estimate of fair value (€5.66)
Significantly Below Fair Value: 1LW is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 1LW?
Key metric: As 1LW is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is 1LW's PS Ratio? | |
|---|---|
| PS Ratio | 0.4x |
| Sales | zł207.34m |
| Market Cap | zł92.55m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.4x |
| Enterprise Value/EBITDA | -44.4x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 1LW's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.7x | ||
BNN BRAIN Biotech | 1.2x | 8.5% | €68.8m |
BIG1 Bio-Gate | 0.8x | 16.3% | €6.3m |
NTG Nabaltec | 0.6x | 5.1% | €123.6m |
2HRA H&R GmbH KGaA | 0.1x | 2.7% | €127.3m |
1LW Polwax | 0.4x | n/a | €92.6m |
Price-To-Sales vs Peers: 1LW is good value based on its Price-To-Sales Ratio (0.4x) compared to the peer average (0.7x).
Price to Sales Ratio vs Industry
How does 1LW's PS Ratio compare vs other companies in the DE Chemicals Industry?
Price-To-Sales vs Industry: 1LW is good value based on its Price-To-Sales Ratio (0.4x) compared to the European Chemicals industry average (1x).
Price to Sales Ratio vs Fair Ratio
What is 1LW's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.4x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate 1LW's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Tokuyama
JP¥196.7b
Produces and sells various chemical products in Japan.
TBT
JP¥16.60
7D
5.7%
1Y
14.5%
Ecora Resources
UK£162.5m
Operates as a natural resource royalty and streaming company in Australia, North and South America, Europe, and internationally.
HGR
UK£0.76
7D
1.5%
1Y
-28.3%
Arkema
€5.7b
Manufactures and sells specialty chemicals and advanced materials worldwide.
V1S
€74.55
7D
-4.4%
1Y
-19.9%